U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Borderline Fallopian Tube Serous Tumor

MedGen UID:
267074
•Concept ID:
C1511257
•
Neoplastic Process
Synonyms: Borderline Fallopian Tube Serous Neoplasm; Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor

Definition

A neoplasm of low malignant potential arising from the fallopian tube. It is characterized by an atypical proliferation of serous-type epithelial cells without evidence of stromal invasion. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVBorderline Fallopian Tube Serous Tumor

Professional guidelines

PubMed

OvaPrint-A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer.
Buckley DN, Lewinger JP, Gooden G, Spillman M, Neuman M, Guo XM, Tew BY, Miller H, Khetan VU, Shulman LP, Roman L, Salhia B
Clin Cancer Res 2023 Dec 15;29(24):5196-5206. doi: 10.1158/1078-0432.CCR-23-1197. PMID: 37812492Free PMC Article
SOX6 Expression Is Sensitive for Peritoneal Epithelioid Malignant Mesothelioma, But Not Specific in the Differential Diagnosis With Tubo-ovarian Serous Neoplasia.
Chapel DB, Hirsch MS
Am J Surg Pathol 2022 Feb 1;46(2):213-219. doi: 10.1097/PAS.0000000000001792. PMID: 34411029
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, Chen LM, Cristea M, DeRosa M, Eisenhauer EL, Gershenson DM, Gray HJ, Grisham R, Hakam A, Jain A, Karam A, Konecny GE, Leath CA, Liu J, Mahdi H, Martin L, Matei D, McHale M, McLean K, Miller DS, O'Malley DM, Percac-Lima S, Ratner E, Remmenga SW, Vargas R, Werner TL, Zsiros E, Burns JL, Engh AM
J Natl Compr Canc Netw 2021 Feb 2;19(2):191-226. doi: 10.6004/jnccn.2021.0007. PMID: 33545690

Recent clinical studies

Etiology

Rare non-serous fallopian tube cancers: institutional experience and literature review.
Sumtsov D, Sumtsov G, Hyriavenko N, Lyndin M, Sikora K, Kalashnik N, Smiian S, Gladchuk I
Wien Med Wochenschr 2024 Jun;174(9-10):199-207. Epub 2023 Nov 28 doi: 10.1007/s10354-023-01027-3. PMID: 38015299
OvaPrint-A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer.
Buckley DN, Lewinger JP, Gooden G, Spillman M, Neuman M, Guo XM, Tew BY, Miller H, Khetan VU, Shulman LP, Roman L, Salhia B
Clin Cancer Res 2023 Dec 15;29(24):5196-5206. doi: 10.1158/1078-0432.CCR-23-1197. PMID: 37812492Free PMC Article
Clinical Presentation of Paraovarian Cysts.
Tzur T, Tzur Y, Baruch S, Smorgick N, Melcer Y
Isr Med Assoc J 2022 Jan;24(1):15-19. PMID: 35077040
Recent concepts of ovarian carcinogenesis: type I and type II.
Koshiyama M, Matsumura N, Konishi I
Biomed Res Int 2014;2014:934261. Epub 2014 Apr 23 doi: 10.1155/2014/934261. PMID: 24868556Free PMC Article
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
Kurman RJ, Shih IeM
Am J Surg Pathol 2010 Mar;34(3):433-43. doi: 10.1097/PAS.0b013e3181cf3d79. PMID: 20154587Free PMC Article

Diagnosis

Rare non-serous fallopian tube cancers: institutional experience and literature review.
Sumtsov D, Sumtsov G, Hyriavenko N, Lyndin M, Sikora K, Kalashnik N, Smiian S, Gladchuk I
Wien Med Wochenschr 2024 Jun;174(9-10):199-207. Epub 2023 Nov 28 doi: 10.1007/s10354-023-01027-3. PMID: 38015299
OvaPrint-A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer.
Buckley DN, Lewinger JP, Gooden G, Spillman M, Neuman M, Guo XM, Tew BY, Miller H, Khetan VU, Shulman LP, Roman L, Salhia B
Clin Cancer Res 2023 Dec 15;29(24):5196-5206. doi: 10.1158/1078-0432.CCR-23-1197. PMID: 37812492Free PMC Article
Clinical Presentation of Paraovarian Cysts.
Tzur T, Tzur Y, Baruch S, Smorgick N, Melcer Y
Isr Med Assoc J 2022 Jan;24(1):15-19. PMID: 35077040
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, Chen LM, Cristea M, DeRosa M, Eisenhauer EL, Gershenson DM, Gray HJ, Grisham R, Hakam A, Jain A, Karam A, Konecny GE, Leath CA, Liu J, Mahdi H, Martin L, Matei D, McHale M, McLean K, Miller DS, O'Malley DM, Percac-Lima S, Ratner E, Remmenga SW, Vargas R, Werner TL, Zsiros E, Burns JL, Engh AM
J Natl Compr Canc Netw 2021 Feb 2;19(2):191-226. doi: 10.6004/jnccn.2021.0007. PMID: 33545690
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.
Kurman RJ
Ann Oncol 2013 Dec;24 Suppl 10:x16-21. doi: 10.1093/annonc/mdt463. PMID: 24265397

Therapy

Low grade serous ovarian cancer - A rare disease with increasing therapeutic options.
Zwimpfer TA, Tal O, Geissler F, Coelho R, Rimmer N, Jacob F, Heinzelmann-Schwarz V
Cancer Treat Rev 2023 Jan;112:102497. Epub 2022 Dec 10 doi: 10.1016/j.ctrv.2022.102497. PMID: 36525716
Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.
Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Pukkala E
Acta Oncol 2016 Nov;55(11):1281-1284. Epub 2016 May 5 doi: 10.1080/0284186X.2016.1175660. PMID: 27148621
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.
Kurman RJ
Ann Oncol 2013 Dec;24 Suppl 10:x16-21. doi: 10.1093/annonc/mdt463. PMID: 24265397
Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.
Ahmed N, Abubaker K, Findlay J, Quinn M
J Cell Biochem 2013 Jan;114(1):21-34. doi: 10.1002/jcb.24317. PMID: 22887554
Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.
Kurman RJ, Shih IeM
Int J Gynecol Pathol 2008 Apr;27(2):151-60. doi: 10.1097/PGP.0b013e318161e4f5. PMID: 18317228Free PMC Article

Prognosis

Rare non-serous fallopian tube cancers: institutional experience and literature review.
Sumtsov D, Sumtsov G, Hyriavenko N, Lyndin M, Sikora K, Kalashnik N, Smiian S, Gladchuk I
Wien Med Wochenschr 2024 Jun;174(9-10):199-207. Epub 2023 Nov 28 doi: 10.1007/s10354-023-01027-3. PMID: 38015299
OvaPrint-A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer.
Buckley DN, Lewinger JP, Gooden G, Spillman M, Neuman M, Guo XM, Tew BY, Miller H, Khetan VU, Shulman LP, Roman L, Salhia B
Clin Cancer Res 2023 Dec 15;29(24):5196-5206. doi: 10.1158/1078-0432.CCR-23-1197. PMID: 37812492Free PMC Article
Recent concepts of ovarian carcinogenesis: type I and type II.
Koshiyama M, Matsumura N, Konishi I
Biomed Res Int 2014;2014:934261. Epub 2014 Apr 23 doi: 10.1155/2014/934261. PMID: 24868556Free PMC Article
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.
Kurman RJ
Ann Oncol 2013 Dec;24 Suppl 10:x16-21. doi: 10.1093/annonc/mdt463. PMID: 24265397
Precursors and pathogenesis of ovarian carcinoma.
Lim D, Oliva E
Pathology 2013 Apr;45(3):229-42. doi: 10.1097/PAT.0b013e32835f2264. PMID: 23478230

Clinical prediction guides

Rare non-serous fallopian tube cancers: institutional experience and literature review.
Sumtsov D, Sumtsov G, Hyriavenko N, Lyndin M, Sikora K, Kalashnik N, Smiian S, Gladchuk I
Wien Med Wochenschr 2024 Jun;174(9-10):199-207. Epub 2023 Nov 28 doi: 10.1007/s10354-023-01027-3. PMID: 38015299
OvaPrint-A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer.
Buckley DN, Lewinger JP, Gooden G, Spillman M, Neuman M, Guo XM, Tew BY, Miller H, Khetan VU, Shulman LP, Roman L, Salhia B
Clin Cancer Res 2023 Dec 15;29(24):5196-5206. doi: 10.1158/1078-0432.CCR-23-1197. PMID: 37812492Free PMC Article
Ciliated Cells in Ovarian Cancer Decrease with Increasing Tumor Grade and Disease Progression.
Richardson MT, Recouvreux MS, Karlan BY, Walts AE, Orsulic S
Cells 2022 Dec 11;11(24) doi: 10.3390/cells11244009. PMID: 36552773Free PMC Article
Differential epithelial and stromal LGR5 expression in ovarian carcinogenesis.
Kim H, Lee DH, Park E, Myung JK, Park JH, Kim DI, Kim SI, Lee M, Kim Y, Park CM, Hyun CL, Maeng YH, Lee C, Jang B
Sci Rep 2022 Jul 1;12(1):11200. doi: 10.1038/s41598-022-15234-2. PMID: 35778589Free PMC Article
Endosalpingiosis: More than just an incidental finding at the time of gynecologic surgery?
Esselen KM, Terry KL, Samuel A, Elias KM, Davis M, Welch WR, Muto MG, Ng SW, Berkowitz RS
Gynecol Oncol 2016 Aug;142(2):255-60. Epub 2016 Jun 3 doi: 10.1016/j.ygyno.2016.05.036. PMID: 27261327

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...